Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

997124

registered interest
date	29/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Housing: Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to promote public awareness of the the effect on people's health of poor quality indoor environments.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	184965
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>Public Health England (PHE) raises public awareness of the impacts of indoor air pollution by supporting activities that aim to change behaviour, such as the annual Clean Air Day, and is working with health partners, such as the National Institute for Health and Care Excellence, World Health Organization and Allergy UK, to improve the evidence on the health impacts of poor indoor air quality which will enhance advice to the public. PHE also promotes awareness about carbon monoxide through the use of blog posts, press releases and social media updates.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2018 16:28:25 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

1010551

registered interest
date	20/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, in light of the Government's commitment that three in four of all cancers be diagnosed at Stage I or II by 2028, what estimate he has made of the proportion of cancer diagnoses for which staging data is currently available; and whether this includes all cancer diagnoses including rare and less common cancers.
tabling member constituency	Basildon and Billericay
tabling member printed	Mr John Baron
uin	193386
answer	answer is ministerial correction date of answer 23/11/2018 answer text <p>In 2016 81.9% of cancers registered by the National Cancer Registration and Analysis Service had a complete stage at diagnosis recorded. This percentage includes all invasive cancers including rare and less common cancers, but excludes non-melanoma skin cancer.</p><p> </p><p>These data, along with data for other United Kingdom countries are published in the United Kingdom and Ireland Association of Cancer Registries (UKIACR). UKIACR Performance Indicators and can be viewed at the following link:</p><p> </p><p><a href="http://www.ukiacr.org/kpis" target="_blank">http://www.ukiacr.org/kpis</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/11/2018 14:14:59 answering member 4067 label Biography information for Steve Brine
tabling member	1390 label Biography information for Mr John Baron

1010555

registered interest
date	20/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prostate Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of changes in the rate of prostate cancer detection since publication of the report of the Prostate Cancer Audit in November 2014.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	193388
answer	answer is ministerial correction date of answer 23/11/2018 answer text <p>There has been no significant change in prostate cancer diagnosis rates between 2014 and 2016 (for which the latest data are available).</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/11/2018 14:16:39 answering member 4067 label Biography information for Steve Brine
tabling member	1409 label Biography information for Mr Gregory Campbell

1010642

registered interest
date	20/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Air Pollution: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with the Secretary of State for Transport on the costs incurred by the NHS in treating conditions caused by air pollution arising from different forms of transport.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	193372
answer	answer is ministerial correction date of answer 23/11/2018 answer text <p>The Secretary of State for Health and Social Care meets with the Secretary of State for Transport regularly to discuss a variety of Government issues.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/11/2018 14:13:21 answering member 4067 label Biography information for Steve Brine
tabling member	308 label Biography information for Mr Jim Cunningham

1010682

registered interest
date	20/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Incinerators: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 July 2018 to Question 164870 on Incinerators: Health Hazards, when those papers will be published.
tabling member constituency	Halton
tabling member printed	Derek Twigg
uin	193404
answer	answer is ministerial correction date of answer 23/11/2018 answer text <p>Public Health England funded the Small Area Health Statistics Unit, and King’s College London, to carry out a study to further extend the evidence base as to whether emissions from modern municipal waste incinerators affect human health.</p><p> </p><p>The first of a series of papers from this study was published on 22 November 2018. The paper ‘Fetal growth, stillbirth, infant mortality and other birth outcomes near UK municipal waste incinerators; retrospective population based cohort and case-control study’ is available to view at the following link:</p><p> </p><p><a href="https://www.sciencedirect.com/science/article/pii/S0160412018316398" target="_blank">https://www.sciencedirect.com/science/article/pii/S0160412018316398</a></p><p> </p><p>The paper found no evidence of a link between exposure to particulate matter emitted from modern municipal waste incinerators as modelled from emissions data, or living close to modern municipal waste incinerators, and infant mortality, low birth weight, still birth or the other birth outcomes investigated.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/11/2018 14:17:44 answering member 4067 label Biography information for Steve Brine
tabling member	429 label Biography information for Derek Twigg

1010706

registered interest
date	20/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 October to Question 180697, how many NHS patients have received a Freestyle Libre glucose monitoring system to date.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	193441
answer	answer is ministerial correction date of answer 23/11/2018 answer text <p>This information is not held centrally.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/11/2018 14:15:52 answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

1010764

registered interest
date	20/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ocrelizumab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of patients with primary progressive multiple sclerosis who could potentially benefit from treatment with Ocrelizumab.
tabling member constituency	Croydon North
tabling member printed	Mr Steve Reed
uin	193600
answer	answer is ministerial correction date of answer 23/11/2018 answer text <p>The Department has made no such assessment. The National Institute for Health and Care Excellence (NICE) is currently developing technology appraisal guidance on the use of ocrelizumab for treating primary progressive multiple sclerosis. The final scope for the appraisal states that 10% of patients with multiple sclerosis have the primary progressive subtype.</p><p> </p><p>Ocrelizumab has a marketing authorisation in the United Kingdom “for the treatment of adult patients with early primary progressive multiple sclerosis in terms of disease duration and level of disability, and with imaging features characteristic of inflammatory activity”. Therefore because of the scope of the marketing authorisation, not every patient with primary progressive multiple sclerosis would be eligible for treatment with ocrelizumab as they must be in the early stages of the disease and have inflammatory activity on MRI.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/11/2018 14:14:05 answering member 4067 label Biography information for Steve Brine
tabling member	4268 label Biography information for Steve Reed

1010186

registered interest
date	19/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	National Institute for Health and Care Excellence: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to his Department’s consultation entitled NICE recommendations: charging and appeal panels which closed on 14 September 2018, what assessment his Department has made of the potential effect on the sustainability of the smallest businesses of (a) charging for NICE appraisals and (b) charging for NICE appraisals at a discounted rate.
tabling member constituency	Sefton Central
tabling member printed	Bill Esterson
uin	192827
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The Government recently consulted on draft amendments to regulations that would enable the National Institute for Health and Care Excellence (NICE) to charge companies for the cost of developing technology appraisal and highly specialised technology evaluation recommendations relating to their products and to allow NICE to recruit appeal panel members representing the National Health Service from the devolved administrations.</p><p> </p><p>The consultation included a draft Impact Assessment and sought views on allowing NICE to charge small companies less and permit small companies to pay in instalments. The charging model in the consultation document proposed a 25% discount for small companies. The Government is currently analysing the responses and will publish its response in due course.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192828 question first answered 22/11/2018 15:08:39 answering member 4067 label Biography information for Steve Brine
tabling member	4061 label Biography information for Bill Esterson

1010187

registered interest
date	19/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	National Institute for Health and Care Excellence: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to his Department’s consultation entitled NICE recommendations: charging and appeal panels which closed on 14 September 2018, what discussions his Department has had with NICE on exempting the smallest companies from the proposed appraisal charges.
tabling member constituency	Sefton Central
tabling member printed	Bill Esterson
uin	192828
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The Government recently consulted on draft amendments to regulations that would enable the National Institute for Health and Care Excellence (NICE) to charge companies for the cost of developing technology appraisal and highly specialised technology evaluation recommendations relating to their products and to allow NICE to recruit appeal panel members representing the National Health Service from the devolved administrations.</p><p> </p><p>The consultation included a draft Impact Assessment and sought views on allowing NICE to charge small companies less and permit small companies to pay in instalments. The charging model in the consultation document proposed a 25% discount for small companies. The Government is currently analysing the responses and will publish its response in due course.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192827 question first answered 22/11/2018 15:08:39 answering member 4067 label Biography information for Steve Brine
tabling member	4061 label Biography information for Bill Esterson

1010304

registered interest
date	19/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Postnatal Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether NHS England has put forward the inclusion of a maternal six-week postnatal check in negotiations on the General Medical Services contract; and what recent progress has been made in those negotiations.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	192896
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The inclusion of a requirement to carry out a six-week postnatal check for all mothers in the general medical services contract would need to be negotiated and agreed, as part of the annual contract negotiations. We have asked for this issue to be considered in the contract negotiations for 2019/20. The details of those negotiations are not generally discussed until an agreement on the way forward has been reached.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192897 question first answered 22/11/2018 11:40:36 answering member 4067 label Biography information for Steve Brine
tabling member	4658 label Biography information for Alex Sobel